Remove Manufacturing Remove Medicine Remove Pharmacology
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. Herbal medicines placed on the market since April 2011 must have either a traditional herbal registration (THR) or a Marketing Authorisation (MA). 2012/1916). 2012/1916). 2012/1916).

Marketing 103
article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

6 There is vast heterogeneity of products available to study owing to there being over 140 cannabinoids identified from the cannabis plant to date Medical cannabis can be manufactured into several formulations, including oils, dried flowers, capsules, suppositories and topical ointments. Expert Review of Clinical Pharmacology.

Medical 98
article thumbnail

Navigating Pharma Sales Challenges: Tips to Boost Your Sales Performance (Use of AI and Social Media for Effective brand promotion)

Pharmaceutical Representative Training

Healthcare professionals can both benefit from posts that highlight the most recent advancements in medicine, stories of achievement, or drug approval information. Frontiers in pharmacology , 7 , 445. Building trust Pharma companies can establish themselves as a reliable authority by providing factual information.

Media 52
article thumbnail

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.

Leads 40
article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development. In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases.

FDA 105
article thumbnail

Considerations for a successful tech transfer of a biologics upstream process

European Pharmaceutical Review

The inevitable shift to external manufacturing sites necessitates a seamless technology transfer process, and should incorporate unique perspectives on local approaches to knowledge transfer, quality, regulatory and all other operational requirements pertaining to the sites locality.